| abstract |
The present invention relates generally to a ligand for a protein associated with modulating obesity, diabetes and metabolic energy levels in animals and humans and to genetic sequences encoding the ligand. More particularly, the present invention is directed to a ligand of the protein "beacon" and its homologues. The identification of the ligand molecule permits the developmen t of a range of therapeutic and diagnostic protocols for obesity, diabetes and energy imbalance. |